Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban

Concomitant use of rivaroxaban with non-dihydropyridine calcium channel blockers (non-DHPs) might lead to an increase of systemic rivaroxaban exposure and anticoagulant effects in relation to the inhibition of metabolic enzymes and/or transporters by non-DHPs. This study was designed to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Minsoo, Son, Heebin, Noh, Keumhan, Kim, Eunyoung, Shin, Beom Soo, Kang, Wonku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470838/
https://www.ncbi.nlm.nih.gov/pubmed/30893910
http://dx.doi.org/10.3390/pharmaceutics11030133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470838/
https://www.ncbi.nlm.nih.gov/pubmed/30893910
http://dx.doi.org/10.3390/pharmaceutics11030133

Ejemplares similares